Recent advances in car t-cell therapy for patients with chronic lymphocytic leukemia

HIGHLIGHTS

• who: Benjamin M. Heyman and collaborators from the Division of Regenerative Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, USA have published the paper: Recent Advances in CAR T-Cell Therapy for Patients with Chronic Lymphocytic Leukemia, in the Journal: Cancers 2022, x of /2022/
• what: The treatment for patients with CLL has changed dramatically over the past decade with introduction of the BCL-2 inhibitor venetoclax, and BTKis.
• future: Future studies investigating whether CAR T_cell therapy may be applicable to high-risk patients such as those who harbor . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.